ICICI Securities maintains a buy call on Mahanagar Gas (MGL) with a target price of Rs 1705, indicating a 28% upside. The brokerage is optimistic about MGL’s long-term prospects, citing strong volume visibility, peer-leading margins, and attractive valuation. They believe the current valuation is significantly below that of its peers, leaving room for growth.
ITC shares in focus after Rs 472 crore acquisition of Sresta Natural Bioproducts
ITC’s shares are set to be in focus following the completion of its acquisition of Sresta Natural Bioproducts for up to Rs 472.5 crore. This acquisition, finalized on June 13, 2025, makes SNBPL a wholly-owned subsidiary and strengthens ITC’s presence in the growing organic food sector, both domestically and internationally, with SNBPL’s established network of farmers and certified organic farmland.
ECB’s Lagarde says 2% inflation target in reach
ECB President Christine Lagarde stated that the central bank is close to achieving its 2% medium-term inflation target, emphasizing financial stability as crucial for price stability. The ECB has lowered its inflation forecasts, projecting 2.0% inflation in 2025 and 1.6% in the coming year. Lagarde also mentioned that the ECB’s digital currency project is nearing readiness, pending legislative approval.
Dalal Street Week Ahead: Technical indicators signal caution, not panic
The Nifty experienced a setback, failing to sustain a breakout from its month-long consolidation phase, closing with a weekly loss of 1.14%. Geopolitical tensions, particularly the Israel-Iran conflict, are expected to influence global equity markets, including India. Despite these uncertainties, the Indian market demonstrates resilience, remaining within the 24500-25100 range.
F&O Talk| Nifty’s narrow range breaks on Iran-Israel tensions; 24,450–24,500 emerges as key support: Sudeep Shah
Amidst escalating geopolitical tensions, Indian markets faced a downturn, with the Nifty and Sensex both declining. Analyst Sudeep Shah suggests a cautious approach, highlighting crucial support levels for the Nifty at 24450 and resistance at 24900. He anticipates pressure on oil marketing and aviation sectors due to rising crude prices, while defense and IT sectors may outperform.
Can rupee recover from its worst fall in over a month due to rising oil prices?
The Indian rupee weakened to 86.20 per dollar due to rising crude oil prices following Israeli strikes on Iran, but closed at 86.08/$1 after likely RBI intervention. Brent crude surged to $75 per barrel, impacting risk sentiment and pushing the 10-year bond yield to 6.40% before settling at 6.36%. Geopolitical tensions created a fragile mood for bonds.
RBI cancels 30-year green bond auction amid high bids
The Reserve Bank of India (RBI) cancelled a ₹5,000 crore green bond auction for the 30-year paper, despite receiving bids exceeding ₹10,943 crore. This cancellation, the second this year, is attributed to bids with yields higher than the RBI’s comfort level. Geopolitical tensions and a weakening rupee contributed to the increased pressure on bond yields, influencing investor expectations.
Indices declines 0.7% amid rising oil prices and geopolitical tensions
Indian equity indices closed lower on Friday due to Israel’s strikes on Iran, which raised concerns about oil supply disruptions and a wider Middle East conflict. Despite an initial sharp fall, the market recovered some losses, supported by underlying bullish sentiment. Both Nifty and Sensex declined, with investors closely watching key support levels for further market direction.
Multibagger factory broken! India’s stock doubling machine produces just 10 winners in 2025
After a blockbuster 2024, Dalal Street’s multibagger engine has lost steam in 2025. Though benchmark indices have bounced back, only 10 stocks with over Rs 1,000 crore market cap have doubled in value so far. Leaders like GHV Infra and RRP Semiconductor are still soaring, but several others are showing signs of fatigue, signalling a tougher road ahead for investors.
Short covering anticipated next week; bullish on 4 pharma & defence stocks: CA Rudramurthy BV
CA Rudramurthy BV sees a buying opportunity in Nifty and Bank Nifty. Nifty is expected to find strong support at 25,000. Bank Nifty has broken above 54,500. Pharma and defence sectors are promising. Divi’s Lab, Laurus Lab, HAL, and BEL are top picks. Attractive opportunities exist in chemicals and insurance.
